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Introduction
Imidazole is a highly polar (dipole moment 3.61D) one of the five-
membered nitrogen containing heterocyclic ring, which is soluble in 
both organic and inorganic polar solvents. It is amphoteric in nature 
and aromatic in character due to the presence of 6 𝜋-electrons. The 
nitrogen attached with the hydrogen has a lone pair of electrons 
bringing the required 6 𝜋-electrons for aromaticity. The hydrogen 
atom can be located on either of the two nitrogen atoms due to 
resonance structures of imidazole [1]. Synthetic chemistry based on 
medicinal compounds concerned with the properties of the starting 
building blocks, their development and evaluation of biological 
activity. The biological activity of the compounds mainly depends upon 
the starting material and mechanism is well-studied at the molecular 
level [2]. The introduction of imidazole nucleus a conventional 
pharmacophore in medicinal compounds have made it versatile 
heterocyclic nucleus possessing wide range of biological activities. 
Imidazole, the core of naturally occurring nucleotides, is responsible 
for their numerous biological activities that allows them to interact 
easily with the biopolymers of the living system and functions [3]. 
Substituted imidazole have good antibacterial activity which revealed 
Abstract
Imidazole derivatives have attracted significant interests in recent time for their usefulness in synthetic heterocyclic 
chemistry, analytical chemistry and pharmacology. Aim of present study was to evaluate the impact of biofield 
treatment on two imidazole derivatives (i.e., imidazole and 2-methylimidazole) by various analytical methods. The 
biofield treatment was done by Mr. Trivedi on both the compounds and both control and treated samples of imidazole 
and 2-methylimidazole were characterized with respect to physical, and structural properties using X-ray diffraction 
(XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier transform infrared (FT-
IR), ultraviolet-visible (UV-Vis) spectroscopy, and Gas chromatography-Mass spectrometry (GC-MS). X-ray diffraction 
study revealed that crystallite size varied in a different way for imidazole and 2-methylimidazole due to the presence 
of methyl group in 2-c position although their core was same. Treated sample of imidazole showed a slight increase 
in crystallite size (6.5%); however, treated 2-methylimidazole showed a significant increase (166.68%) in crystallite 
size along with decrease in peak intensity as compared to control. The latent heat of fusion (ΔH) of imidazole was 
increased up to 0.62% in treated sample as compared to control; whereas in treated 2-methylimidazole, the ΔH 
was decreased by 22% as compared to control. Maximum degradation temperature (Tmax) from TGA of imidazole 
was remained same but 2-methylimidazole was increased by 1.5% as compared to control. FT-IR spectra showed 
slight change in stretching frequencies of treated imidazole and 2-methylimidazole as compared to control. Both the 
imidazole and 2-methylimidazole showed similar UV absorbance maxima as compared to respective control sample. 
GC-MS data revealed that isotopic abundance ratio of either 13C/12C or 15N/14N or 2H/1H (PM+1/PM) of treated imidazole 
was significantly increased up to 232.51% as compared to control, however, isotopic abundance ratio of 13C/12C or 
15N/14N or 2H/1H (PM+1/PM) of treated 2-methylimidazole showed a minor change from -1.68 upto 1.68% as compared 
to control. Overall, the experimental results suggest that biofield treatment has significant effect on structural and 
thermal properties of imidazole and 2-methylimidazole. 
good inhibition against various tested microbial strains. Vijesh et al. 
reported that some of the imidazole derivatives (3-aryl-1H-imidazole-
4-carbaldehyde thiosemicarbazones) have excellent activity even better 
than standard drug, i.e., streptomycin against Pseudomonas aeruginosa 
and Clostridium perfringens [4]. Ucucu et al. had reported that synthetic 
1-benzyl-2-substituted-4,5-diphenyl-1H-imidazole derivative worked 
well as analgesic on Swiss albino mice of both sexes. One of the 
derivative of imidazole has shown responses very close to morphine 
[5]. A newly synthesized compound, N-cyano substituted imidazole 
derivatives has shown fungicidal activities against Rhizoctonia solani, 
at a concentration of 50 µg/mL.  This compound has identified as the 
most potent candidate with an EC50 of 2.63 µg/mL against Rhizoctonia 
Solani [6].  Yang et al. has been reported that substitution of the 
imidazolyl-3-position with a naphthylacyl or bromophenacyl group, 
vital for modifying its cytotoxic activity [7]. 
The chemical or physical stability is the most anticipated quality of 
a molecule to be used in pharmaceutical purposes. In order to increase 
its shelf life and effectiveness there is a need to increase the stability 
of the compound both chemically as well as physically. The stability 
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TGA/DTG results were obtained by using Mettler Toledo 
simultaneous thermogravimetric analyzer at a heating rate of 5°C/min 
from room temperature to 400°C under air atmosphere (sample mass 
5-10 mg on aluminium pan). 
Percent change in temperature at which maximum weight loss 
occur in sample was calculated using following equation:
% change in Tmax=[(Tmax, treated − Tmax, control) / Tmax, control] × 100
Where, Tmax, control and Tmax, treated are temperature at which 
maximum weight loss occurs in control and treated sample, 
respectively.
FT-IR spectroscopic characterization
FT-IR spectra were acquired on Shimadzu’s Fourier transform 
infrared spectrometer (Japan) with frequency range of 500-4000 cm-1. 
The imidazole derivatives were run as pressed disks using KBr as the 
diluent.
UV-Vis spectroscopic analysis
Photophysical properties were studied by Shimadzu UV-2400 PC 
series spectrophotometer with 1 cm quartz cell and a slit width of 2.0 
nm, wavelength was in the range of 200-400 nm. 
GC-MS analysis 
The Gas chromatography-Mass spectrometry (GC-MS) analysis 
was performed on Perkin Elmer/auto system XL with Turbo Mass, 
USA, having detection limit up to 1 picogram. For GC-MS analysis 
the treated samples were further divided into four parts as T1, T2, T3 
and T4. The GC-MS data was obtained in the form of % abundance 
vs. mass to charge ratio (m/z), which is known as mass spectrum. 
The isotopic ratio of PM+1/PM was expressed by its deviation in 
treated samples as compared to the control. The collective effect of 
the isotopic abundance ratio of (PM+1/PM) of treated samples were 
calculated from the following formula:
Percent change in isotopic abundance
 Treated control
control
R R   100
R
−
= ×    .………………. (1)
Where, RTreated and RControl are the ratio of intensity of masses from 
the mass spectrometry for treated and control samples respectively.  
Results and Discussion
X-ray diffraction studies 
X-ray diffraction study was conducted on both control and 
treated samples of imidazole derivatives and their diffractograms are 
shown in Figure 1. As both the imidazole and 2-methyl imidazole 
(control and treated) were crystalline in nature so they exhibited very 
sharp and intense peaks (6000-30000 a.u.) in their respective X-ray 
diffractograms. The X-ray diffractogram of control imidazole showed 
peaks at 2θ equals to 12.89°, 19.14°, 20.31°, 20.74° 25.66°, 25.91° and 30.73° 
whereas the X-ray diffractogram of treated imidazole showed peaks at 
2θ equals to 13.01°, 20.31°, 20.93°, 26.08°, 30.74°, and 30.87°. In control 
sample of 2-methylimidazole, the X-ray diffractogram showed peaks 
at 2θ equals to 17.49°, 17.76°, 21.77°, 25.87° and 26.17° where the treated 
2-methylimidazole showed peaks at 2θ equals to 17.34°, 17.59°, 17.80°, 
21.19°, 25.88° and 26.16°. XRD studies showed that crystal structure of 
imidazole was monoclinic and orthorhombic structure was found for 
2-methylimidazole, which were well supported by reported literature 
data [18]. 
could be enhanced by Mr. Trivedi’s biofield treatment which is already 
known to alter the physical, and structural properties of various living 
and non-living substances [8]. The biofield is the electromagnetic field 
which surrounds the human body can be harnessed from the universe 
and have applied on materials by experts in a controlled way to make 
the changes [9,10]. This phenomenon is experimentally demonstrated 
by researchers using medical technologies such as electromyography, 
electrocardiography and electroencephalogram [9]. Mr. Trivedi has the 
ability to harness the energy from the universe and can transmit into 
any object, living or nonliving things [11]. Mr. Trivedi’s unique biofield 
treatment is also known as The Trivedi Effect® which has been applied 
in various research fields including microbiology [12], agriculture, 
[13,14] and biotechnology [15]. The stability of the complexes with 
both imidazole derivatives taken for this study depends mostly on the 
substituent situated between the nitrogen atoms of the imidazole ring 
[16]. Imidazole containing organic materials have better solubility 
in common polar organic and inorganic solvents compared to other 
heterocyclic moieties [17]. So in this study, Mr. Trivedi’s biofield 
treatment was applied to treat imidazole derivatives for evaluation of 
their physical, thermal and spectral properties as compared to control.
Materials and Methods
Study design
Imidazole and 2-methylimidazole were procured from Lobachemie 
Pvt. Ltd., India. Each compound was divided into two parts and 
coded as control and treatment. The control samples were remained 
as untreated and treatment samples were in sealed pack were handed 
over to Mr. Trivedi for biofield treatment in laboratory conditions. 
Mr. Trivedi provided this treatment through his energy transmission 
process to the treatment groups. The control and treated samples were 
evaluated using various spectroscopic, thermal and physical techniques.
X-ray diffraction (XRD) study
XRD analysis was carried out on Phillips, Holland PW 1710 X-ray 
diffractometer system, with radiation of wavelength 1.54056 Å. The 
crystallite size (G) was calculated by using formula: 
G=kλ/(bCosθ)
Here, λ is the wavelength of radiation, b is full width half maximum 
(FWHM) of peaks and k is the equipment constant (=0.94). The average 
value of G was taken for both control (Gc) and treated (Gt) samples to 
calculate % change in crystallite size. 
Percent change in crystallite size=[(Gt-Gc)/Gc] × 100
Differential scanning calorimetry (DSC) study 
DSC data were obtained by using Perkin Elmer/Pyris-1, USA at 
flow rate of 5 ml/min using closed aluminum pan. Melting temperature 
and latent heat of fusion were obtained from the DSC curve.  
Percent change in latent heat of fusion was calculated using 
following equation 
[ ]Treated Control
Control
H H 
% change in Latent heat of fusion 100 
H 
∆ −∆
= ×
∆
Where, ΔH Control and ΔH Treated are the latent heat of fusion of control 
and treated samples, respectively.
Thermogravimetric analysis (TGA)/ derivative thermogra-
vimetry (DTG)
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In case of imidazole crystallite size was increased to 6.5%, however 
for 2-methylimidazole, crystallite size increased significantly up to 
166.68% (Table 1). It is presumed that biofield energy may be absorbed 
by the treated imidazole molecules which may lead to the formation 
of crystalline long range pattern attributed to the high intensity of 
the XRD peaks. It was reported in previous literature that thermal 
annealing increase the crystallite size and thereby increase the intensity 
of the peaks [19,20]. After biofield treatment imidazole derivatives 
may absorbed high energy which enhances the crystallite size of the 
treated imidazole. The volume of unit cell of treated 2-methylimidazole 
was increased from 485.83 × 10-24 cm3 to 497.32 × 10-24 cm3 as 2.37% 
compared to control. 
DSC analysis
The DSC analysis results of control and treated samples of 
imidazole and its derivative are presented in Table 2. The latent heat 
of fusion (ΔH), was increased for imidazole molecule from 158.8 to 
159.5 J/g whereas, ΔH decreased from 137.2 J/g (control) to 106 
J/g (treated) for 2-methylimidazole. There may be biofield energy 
favoring a strong ‘C-H····N’ H-binding interaction of methyl hydrogen 
in 2-methylimidazole. Higher melting point of 2-methylimidazole 
compared to imidazole was attributed to stronger H-bonding 
interactions via methyl ‘H’ atoms and ring ‘N’ atoms [21]. This result 
cannot be seen in imidazole as the ‘methyl-H’ portion is absent in this 
molecule. As a result, treated 2-methyl imidazole sample needed less 
energy in the form of ΔH to undergo the process of melting. However, 
imidazole does not have methyl group and any changes in ΔH have 
not seen of melting for control and treated samples. The DSC result of 
treated imidazole (90.19°C) did not show significant change in melting 
temperature as compared to control 89.86°C. However, melting point 
of 2-methylimidazole was increased 147°C as compared to control 
(145°C), i.e., change in 1.4% [22]. It is hypothised that biofield energy 
may be absorbed by 2-methylimidazole molecule which possibly 
lowered the torsional strain exerted by the methyl-H atoms.
TGA/DTG analysis
TGA thermogram (Figure 2a) showed that treated imidazole 
compound was less thermally stable than control sample. The onset 
degradation temperature for imidazole was at 170°C for control 
but 160°C for treated sample. The end-set degradation temperature 
was observed at 250°C for control and 235°C for treated sample, 
respectively. The decrease in thermal stability of imidazole to 6% 
may have increased the reactivity which may contribute to the lesser 
reaction time and temperature in production of imidazole derivatives. 
But in case of 2-methylimidazole control sample (Figure 2b) started 
degrading around 140°C (onset) and stopped at 245°C (end-set). 
Besids this, treated 2-methylimidazole showed onset degradation 
temperature at ~152°C and end-set around 240°C. It indicated that 
onset temperature of treated 2-methylimidazole was increased by 8% as 
compared to control (Figure 2b). Furthermore, in this process, control 
2-methylimidazole sample lost ~97% and treated sample lost 74% of 
its weight. DTG thermogram showed Tmax~192°C in control, whereas, 
it was increased to ~195°C in treated 2-methylimidazole. Thermal 
stability of 2-methylimidazole from Tmax was increased by 1.5% as 
compared to control. The increase in onset temperature, Tmax, and end-
set temperature of the treated samples of 2-methylimidazole can be 
related to increase in thermal stability of treated molecule. The overall 
increases in thermal stability of treated 2-methylimidazole might be 
advantageous to be used as core moiety (pharmacophore) in medicine 
and synthetic biopolymers. 
UV-Vis spectroscopy 
UV spectra of control and biofield treated imidazole and 2-methyl 
imidazole are shown in Figure 3. Imidazole derivatives absorb UV 
light due to the presence of conjugated pi (π) bonding systems (π - π* 
transition) and nonbonding electron system (n - π* transition). There 
are certain energy gaps between π  -  π* and n -  π* orbitals. From the 
above experiments, it was observed that negligible structural changes 
occurred in treated samples as compared to control, which was not 
sufficiently large to alter UV-Visible spectral properties in solution 
state.  Treated sample of imidazole (Figure 3) exhibited hypsochromic 
effect (1 nm change) in absorbance maxima (λmax) at 207 nm compared 
to control at 208 nm. Whereas, treated 2-methylimidazole exhibited 
bathochromic shift at the absorbance maxima (λmax) 206 nm compared 
to 205 nm for control.
FT-IR spectroscopic analysis
FTIR spectra of control and treated samples of imidazole and 
2-methylimidazole are presented in (Figures 4a and 4b) respectively. 
Secondary amine N-H stretching frequency was observed at 3018 cm-1 
for control and 3020 cm-1 for treated sample of imidazole. IR spectra 
of both control and treated imidazole sample showed C-N stretching 
at 1448 cm-1 and out of plane NH2 bending at 659 cm-1. In case of 
2-methylimidazole N-H stretching was seen at 3020 cm-1 (control) 
and 3018 cm-1 (treated). These data indicated that there was slight 
changes in the hydrogen bonding environment in both treated and 
control samples of both imidazole and 2-methylimidazole. The broad 
absorption peaks were observed in the wavenumber ranges from 3400-
2600 cm-1 for both control and treated samples assigned to bonding 
vibration of water molecules due to moisture absorption by samples 
[23]. In the FT-IR spectrum of imidazole showed a minor changes in 
the C-H stretching at 2791 cm-1 for control and 2794 cm-1 for treated 
one. Whereas in case of 2-methylimidazole C-H stretching frequency 
was observed at 2681 cm-1 for control and 2690 cm-1 for treated sample. 
The N-H bending for imidazole was observed at 1541 cm-1 for both 
control and treated samples, while in case of 2-methyl imidazole N-H 
bending was observed at 1595 cm-1 for both control and treated. The 
C-H deformation bends were assigned to the peaks at 1301 cm-1 in 
and treated sample of 2-methylimidazole. The FT-IR results showed 
little changes in other vibrational frequencies for the N-H and C-H 
stretching frequencies, as well as bending vibration energies, which 
lead to the changes in packing parameters of imidazole crystal after 
biofield treatment validating the DSC and XRD results incorporated 
here. 
Figure 1: XRD diffractogram of control and treated samples of imidazole and 
2-methylimidazole.
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Organic compound Imidazole 2-Methyl Imidazole
Crystal Structure Group Monoclinic Orthorhombic
Volume of unit cell
× 10-24 cm3
Control ˗ 485.83
Treatment ˗ 497.32
% Change in volume of unit cell Treatment ˗ 2.37
Crystallite size
‘G’ × 10-9 m
Control 85.83 52.33
Treatment 91.39 139.56
% change in ‘G’ Treatment 6.5 166.68
Table 1: XRD analysis of control and treated samples of imidazole and 2-methylimidazole. -: Not reported.
Figure 2 (a): TGA thermogram of control and treated imidazole.
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Figure 2 (b): TGA thermogram of control and treated 2-methylimidazole.
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Figure 3: UV spectra of control and treated samples of imidazole and 
2-methylimidazole.
Figure 4 (a): FT-IR spectra of control and treated samples of imidazole.
Figure 4 (b): FT-IR spectra of control and treated samples of 
2-methylimidazole.
Figure 5 (a): GC-MS spectra of control and treated (T1 and T2) samples of 
imidazole.
Figure 5 (b): GC-MS spectra of treated (T3 and T4) samples of imidazole.
Figure 5 (c): GC-MS spectra of control and treated (T1 and T2) samples 
of 2-methylimidazole.
GC-MS spectrometry 
The mass spectrum of control and treated samples of imidazole and 
2-methylimidazole are shown in Figures 5a-5d. Treated samples were 
divided into four parts (T1, T2, T3 and T4) and analyzed at different 
times. Isotopic abundance ratio of 13C/12C or 15N/14N or 2H/1H (PM+1/
PM) in imidazole, determined using equation (1) is shown in Table 3. 
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Parameter Imidazole 2-methylimidazole
Latent heat of fusion ΔH (J/g) Control 158.8 137.2
Treatment 159.5 106.2
Melting point (ºC) Control 89.8 145.7
Treatment 90.2 147
Table 2: DSC analysis of control and treated samples of imidazole and 2-methylimidazole.
Molecular
formulae/name
Molecular mass Ratio of peak intensity
Observed (PM+1/PM)
% Change in (PM+1/PM) (Between control and treated)
C3H4N2
Imidazole
68 Control 4.86 -
T1 4.82 -0.82
T2 5.73 17.90
T3 6.23 28.19
T4 16.16 232.51
C4H6N2
2-methyl
imidazole
82 Control 5.37
T1 5.28 -1.68
T2 5.20 -3.17
T3 5.45 1.49
T4 5.46 1.68
Table 3: Analysis of isotopic abundance of imidazole and 2-methylimidazole using gas chromatography mass-spectrometry (GC-MS). PM: primary molecule (m/z=68 for 
imidazole, m/z=82 for 2-methyl imidazole); PM+1: isotopic molecule (m/z=69 for imidazole and m/z=83 for 2-methylimidazole).
It showed that the isotopic ratio of 13C/12C or 15N/14N or 2H/1H (PM+1/
PM) in imidazole was significantly increased by 232.51% in sample T4, 
while it was increased by only 1.68% in treated (T4) 2-methylimidazole 
as compared to control. The biofield treatment may have altered the 
natural abundance ratio of 13C/12C or 15N/14N or 2H/1H (PM+1/PM) 
of T4-imidazole from the control samples. Furthermore, it is assumed 
that imidazole molecule with higher isotopic ratio of 13C/12C or 15N/14N 
or 2H/1H (PM+1/PM), (T4), might have higher stability due to the 
increased µ (reduced mass) and binding energy in molecules with 
heavier isotopes. The heavier isotopes may form one of the following 
bonds like 13C-12C, 13C-13C, 13C-14N, 12C-15N, 13C-2H, 15N-2H, and 13C-H 
as compared to control. [24]. This higher binding energy may lead to 
increase the heat of reaction for imidazole T4 and reverse might happen 
in treated T1. Thus, GC-MS data suggested that biofield treatment has 
significantly altered the isotopic ratio of 13C/12C or 15N/14N or 2H/1H 
(PM+1/PM) to 232.51%, in treated imidazole molecule whereas isotopic 
ratio of PM+1/PM has remained same in treated 2-methylimidazole as 
compared to control. 
Conclusion
In summary, the biofield treatment offers a remarkable means to 
alter the properties of imidazole and 2-methylimidazole at molecular 
level. Due to biofield treatment on 2-methylimidazole, crystallite size 
was significantly increased up to 166.68% by means of increasing the 
volume of unit cell in a crystal but imidazole has very small change 
in crystallite size up to 6.5% in XRD study. GC-MS data revealed that 
isotopic abundance ratio of 13C/12C or 15N/14N or 2H/1H (PM+1/PM) 
of treated imidazole was significantly changed 232.51% of T4 sample 
as compared to control, however, treated 2-methylimidazole showed 
a minor change (1.68%) as compared to control. It is assumed that 
the enhancement in thermal stability of 2-methylimidazole could be 
more useful as a building block in various pharmaceutical products and 
biopolymers of pharmaceutical importance, which ultimately affect the 
shelf-life and efficacy of drug. Moreover, the treated imidazole found to 
be thermally less stable compared to control may be useful as reaction 
intermediate for various chemical reactions or it can be converted to 
2-substituted imidazole for better stability. Furthermore, due to high 
isotopic abundance ratio of 13C/12C or 15N/14N or 2H/1H (PM+1/PM) 
of treated (T4) imidazole, bond might have highly stable with higher 
binding energy may lead to higher chemical stability than the control.
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